EUVIMEDEUVIMED entdecken
Crossref

Changes in Diagnostic Methods, Criteria, and Treatment for Chronic Endometritis After National Health Insurance Coverage of Assisted Reproductive Technology in Japan: A Nationwide Follow‐up Survey ( IZANAMI Project)

Seung Chik Jwa iD, Keiji Kuroda iD, Hiromitsu Shirasawa iD, Miyuki Harada, Yutaka Osuga, Mitsutoshi Yamada iD

Journal of Obstetrics and Gynaecology Research · 2026

DOI: 10.1111/jog.70271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Seung Chik Jwa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan. Hauptthemen laut MEDLINE: Endometritis, Reproductive Techniques, Assisted, National Health Programs, Insurance Coverage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate how diagnostic methods, criteria, and treatment for chronic endometritis (CE) changed in Japan after introducing health insurance coverage of assisted reproductive technology (ART).

Methods

We conducted two nationwide, web‐based facility surveys targeting all 616 registered ART facilities. The surveys were administered before ART insurance coverage (December 2021 to February 2022) and after coverage (December 2023 to January 2024). Facilities that responded to both surveys (283 facilities) were included. We evaluated whether facility‐level CE diagnostic methods, CD138‐positive plasma cell cutoff values, and first‐ and second‐line treatment choices changed between surveys.

Results

CE testing was implemented by 238 facilities in the precoverage and 244 postcoverage periods. The adoption of diagnostic methods did not significantly change. Although the overall number of facilities that adopted CD138 immunohistochemical staining was stable (145 vs. 149 facilities), 23 facilities discontinued CD138 staining postcoverage while 27 newly introduced it; discontinuation occurred predominantly in clinics (91.3%), whereas 44% of new adopters were hospitals/university hospitals ( p < 0.001). The cutoff value of CD138‐positive cells (6–10 cells/20 high‐power fields) increased between the surveys ( p = 0.01). Doxycycline remained the first‐line therapy. Regarding second‐line therapy, ciprofloxacin plus metronidazole remained the most frequent, while probiotics significantly increased ( p = 0.005).

Conclusions

After ART insurance coverage in Japan, overall CE diagnostic methods and CD138 adoption remained largely unchanged. However, facilities tended to adopt higher CD138 cutoff values and treatment selections shifted. Establishing unified diagnostic criteria and treatment protocols is warranted to support standardized CE care for future health insurance coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometritisReproductive Techniques, AssistedNational Health ProgramsInsurance CoverageHumansFemaleJapanChronic DiseaseFollow-Up Studies

Stichwörter der Autor:innen

CD138assisted reproductive technologychronic endometritishealth insurance coveragenationwide survey

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan.
  • Center for Reproductive Medicine and Endoscopy, Sugiyama Clinic Marunouchi, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine, Akita, Japan.
  • Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Japan.
  • Teikyo Academic Research Center, Teikyo University, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

ORCID-Profile: Seung Chik Jwa, Keiji Kuroda, Hiromitsu Shirasawa, Mitsutoshi Yamada

Zitieren

APA

Jwa, S. C., Kuroda, K., Shirasawa, H., Harada, M., Osuga, Y., & Yamada, M. (2026). Changes in Diagnostic Methods, Criteria, and Treatment for Chronic Endometritis After National Health Insurance Coverage of Assisted Reproductive Technology in Japan: A Nationwide Follow‐up Survey ( IZANAMI Project). Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70271

Vancouver

Jwa SC, Kuroda K, Shirasawa H, Harada M, Osuga Y, Yamada M. Changes in Diagnostic Methods, Criteria, and Treatment for Chronic Endometritis After National Health Insurance Coverage of Assisted Reproductive Technology in Japan: A Nationwide Follow‐up Survey ( IZANAMI Project). Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70271

BibTeX
@article{Jwa2026,
  author = {Jwa, Seung Chik and Kuroda, Keiji and Shirasawa, Hiromitsu and Harada, Miyuki and Osuga, Yutaka and Yamada, Mitsutoshi},
  title = {Changes in Diagnostic Methods, Criteria, and Treatment for Chronic Endometritis After National Health Insurance Coverage of Assisted Reproductive Technology in Japan: A Nationwide Follow‐up Survey ( IZANAMI Project)},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  doi = {10.1111/jog.70271}
}
Kostenlos starten →